KAROLINE MION: Open Payments
NPI 1346671757 · DEERFIELD BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 31 payments from 12 companies in 2025. Trend: 2023 $611 · 2024 $248 · 2025 $862
Food & beverage: $751Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $149 |
| Axsome Therapeutics, Inc. | 4 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Tris Pharma Inc | 4 | $80 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Indivior Inc. | 1 | $24 |
| Resmed Corp | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, Auvelity, Dyanavel XR, Qelbree, REXULTI, TRINTELLIX, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
